Mina Tabrizi

3.1k total citations
75 papers, 2.4k citations indexed

About

Mina Tabrizi is a scholar working on Molecular Biology, Psychiatry and Mental health and Immunology. According to data from OpenAlex, Mina Tabrizi has authored 75 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Molecular Biology, 20 papers in Psychiatry and Mental health and 15 papers in Immunology. Recurrent topics in Mina Tabrizi's work include Schizophrenia research and treatment (11 papers), Tryptophan and brain disorders (7 papers) and Attention Deficit Hyperactivity Disorder (7 papers). Mina Tabrizi is often cited by papers focused on Schizophrenia research and treatment (11 papers), Tryptophan and brain disorders (7 papers) and Attention Deficit Hyperactivity Disorder (7 papers). Mina Tabrizi collaborates with scholars based in Iran, United States and Germany. Mina Tabrizi's co-authors include Shahin Akhondzadeh, Taolin Yi, Amirhossein Modabbernia, Mandana Ashrafi, Farzin Rezaei, Wentian Yang, Karim Berrada, Ali Ghaleiha, Bahman Salehi and Huaiyuan Jiao and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Mina Tabrizi

74 papers receiving 2.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mina Tabrizi Iran 28 686 657 438 425 357 75 2.4k
Paulo Fontoura Switzerland 26 1.1k 1.6× 403 0.6× 538 1.2× 257 0.6× 365 1.0× 91 3.6k
Souhel Najjar United States 21 511 0.7× 661 1.0× 181 0.4× 116 0.3× 646 1.8× 37 2.5k
Yuichiro Watanabe Japan 25 642 0.9× 231 0.4× 134 0.3× 195 0.5× 389 1.1× 110 2.2k
Janine Doorduin Netherlands 24 590 0.9× 437 0.7× 198 0.5× 138 0.3× 1.1k 3.1× 92 3.1k
Carole Rovère France 32 816 1.2× 177 0.3× 352 0.8× 397 0.9× 178 0.5× 63 2.8k
M. Axel Wollmer Germany 25 954 1.4× 351 0.5× 91 0.2× 151 0.4× 108 0.3× 56 2.9k
Hassan Rahmoune United Kingdom 30 864 1.3× 519 0.8× 143 0.3× 84 0.2× 994 2.8× 61 2.4k
Hywel Williams United Kingdom 37 1.8k 2.6× 679 1.0× 156 0.4× 238 0.6× 193 0.5× 101 4.2k
Makoto Inoue Japan 40 1.9k 2.7× 436 0.7× 505 1.2× 250 0.6× 114 0.3× 85 4.4k
Vibeke S. Catts Australia 23 862 1.3× 574 0.9× 130 0.3× 102 0.2× 1.1k 3.2× 48 2.7k

Countries citing papers authored by Mina Tabrizi

Since Specialization
Citations

This map shows the geographic impact of Mina Tabrizi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mina Tabrizi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mina Tabrizi more than expected).

Fields of papers citing papers by Mina Tabrizi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mina Tabrizi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mina Tabrizi. The network helps show where Mina Tabrizi may publish in the future.

Co-authorship network of co-authors of Mina Tabrizi

This figure shows the co-authorship network connecting the top 25 collaborators of Mina Tabrizi. A scholar is included among the top collaborators of Mina Tabrizi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mina Tabrizi. Mina Tabrizi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kim, Hern, et al.. (2024). 441P Development of a novel fusion protein, JUV-161, that enhances muscle regeneration for treatment of myotonic dystrophy type 1. Neuromuscular Disorders. 43. 104441.516–104441.516. 2 indexed citations
2.
Setoodeh, Aria, Farzaneh Abbasi, Azadeh Sayarifard, et al.. (2022). Molecular and clinical characterization of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy syndrome (APECED) in Iranian non-Jewish patients: report of two novel AIRE gene pathogenic variants. Orphanet Journal of Rare Diseases. 17(1). 10–10. 3 indexed citations
3.
4.
Yaseri, Mehdi, et al.. (2020). Increased Expression of ZEB1 in Glioma. 1 indexed citations
5.
Kajbafzadeh, Abdol‐Mohammad, Hamid Arshadi, Aria Setoodeh, et al.. (2019). Molecular investigation of mutations in androgen receptor and 5‐alpha‐reductase‐2 genes in 46,XY Disorders of Sex Development with normal testicular development. Andrologia. 51(5). e13250–e13250. 5 indexed citations
6.
Azarnezhad, Asaad, et al.. (2018). Detection of CCND1 , C-MYC , and FGFR1 amplification using modified SYBR Green qPCR and FISH in breast cancer. TURKISH JOURNAL OF MEDICAL SCIENCES. 48(4). 759–767. 1 indexed citations
7.
Karami, Fatemeh, Mohammad Reza Noori–Daloii, Kobra Omidfar, et al.. (2018). Modified methylated DNA immunoprecipitation protocol for noninvasive prenatal diagnosis of Down syndrome. Journal of obstetrics and gynaecology research. 44(4). 608–613. 7 indexed citations
8.
Raoofian, Reza, Leila Youssefian, Hassan Vahidnezhad, et al.. (2014). BMI1 and TWIST1 Downregulated mRNA Expression in Basal Cell Carcinoma. Asian Pacific Journal of Cancer Prevention. 15(8). 3797–3800. 5 indexed citations
9.
Rezaei, Farzin, Amirhossein Modabbernia, Mandana Ashrafi, et al.. (2013). Memantine Add-On to Risperidone for Treatment of Negative Symptoms in Patients With Stable Schizophrenia. Journal of Clinical Psychopharmacology. 33(3). 336–342. 50 indexed citations
10.
Shokrgozar, Mohammad Ali, et al.. (2013). Mercury specifically induces LINE-1 activity in a human neuroblastoma cell line. Mutation Research/Genetic Toxicology and Environmental Mutagenesis. 759. 9–20. 16 indexed citations
11.
Jadidi‐Niaragh, Farhad, Ghasem Ghalamfarsa, Mehdi Yousefi, Mina Tabrizi, & Fazel Shokri. (2013). Regulatory T cells in chronic lymphocytic leukemia: implication for immunotherapeutic interventions. Tumor Biology. 34(4). 2031–2039. 46 indexed citations
12.
Modabbernia, Amirhossein, Hamid R. Sohrabi, Firoozeh Raisi, et al.. (2012). Effect of saffron on fluoxetine-induced sexual impairment in men: randomized double-blind placebo-controlled trial. Psychopharmacology. 223(4). 381–388. 89 indexed citations
13.
Sanati, Mohammad Hossein, Masih Tajdini, Amirhossein Modabbernia, et al.. (2012). Granisetron Adjunct to Fluvoxamine for Moderate to Severe Obsessive-Compulsive Disorder. CNS Drugs. 26(10). 883–892. 45 indexed citations
14.
Modabbernia, Amirhossein, Farzin Rezaei, Bahman Salehi, et al.. (2012). Intranasal Oxytocin as an Adjunct to Risperidone in Patients with Schizophrenia. CNS Drugs. 27(1). 57–65. 89 indexed citations
15.
Farokhnia, Mehdi, et al.. (2012). Oral Scopolamine Augmentation in Moderate to Severe Major Depressive Disorder. The Journal of Clinical Psychiatry. 73(11). 1428–1433. 66 indexed citations
16.
Abbasi, Seyed-Hesameddin, et al.. (2011). Acetyl-L-Carnitine as an Adjunctive Therapy in the Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents: A Placebo-Controlled Trial. Child Psychiatry & Human Development. 42(3). 367–375. 26 indexed citations
17.
18.
Tabrizi, Mina, et al.. (2010). Venlafaxine versus methylphenidate in pediatric outpatients with attention deficit hyperactivity disorder: a randomized, double‐blind comparison trial. Human Psychopharmacology Clinical and Experimental. 25(7-8). 530–535. 32 indexed citations
19.
Rezaei, Farzin, Bahman Salehi, Amirhossein Modabbernia, et al.. (2010). Double-blind, randomized, placebo-controlled 6-week study on the efficacy and safety of the tamoxifen adjunctive to lithium in acute bipolar mania. Journal of Affective Disorders. 129(1-3). 327–331. 72 indexed citations
20.
Rezazadeh, Shamsali, et al.. (2010). Amantadine versus methylphenidate in children and adolescents with attention deficit/hyperactivity disorder: a randomized, double‐blind trial. Human Psychopharmacology Clinical and Experimental. 25(7-8). 560–565. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Paulo Fontoura Breakdown of academic impact, for papers by Souhel Najjar Breakdown of academic impact, for papers by Yuichiro Watanabe Breakdown of academic impact, for papers by Janine Doorduin Breakdown of academic impact, for papers by Carole Rovère Breakdown of academic impact, for papers by M. Axel Wollmer Breakdown of academic impact, for papers by Hassan Rahmoune Breakdown of academic impact, for papers by Hywel Williams Breakdown of academic impact, for papers by Makoto Inoue Breakdown of academic impact, for papers by Vibeke S. Catts
Rankless by CCL
2026